Melanoma-Derived Growth Regulatory Protein (MIA) Antibody

Este producto es parte de MIA - MIA SH3 domain containing
Melanoma-Derived Growth Regulatory Protein (MIA) Antibody
884€ (1 ml)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
Melanoma-Derived Growth Regulatory Protein (MIA) Antibody
Category
Primary Antibodies
Provider
Abbexa
Reference
abx173529
Tested Applications
WB, IHC, IF/ICC

Description

This product is currently in development. The lead time for this product may be several months. Please contact us at

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Primary Antibodies
Immunogen Target
Target: Melanoma-Derived Growth Regulatory Protein (MIA)
Host
Mouse
Reactivity
Rat
Recommended Dilution
WB: 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Purified by Protein A and Protein G affinity chromatography.
Size 1
1 ml
Form
Liquid
Tested Applications
WB, IHC, IF/ICC
Buffer
0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol.
Availability
Please enquire.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Alias
Melanoma inhibitory activity protein,MIA1,CD-RAP
Background
Antibody anti-MIA
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

MIA, also known as Melanoma Inhibitory Activity, is a small secreted protein primarily expressed in melanocytes and chondrocytes, where it regulates cell adhesion, migration, and tumor progression It acts by disrupting the interaction between integrins and the extracellular matrix, facilitating detachment and migration of tumor cells MIA is highly expressed in malignant melanoma and is used as a biomarker for disease progression, metastasis, and treatment monitoring Elevated MIA levels are also observed in other cancers, such as chondrosarcoma and hepatocellular carcinoma, where it contributes to tumor invasiveness Its role extends to cartilage homeostasis and chondrocyte differentiation, implicating MIA in cartilage-related disorders like osteoarthritis Targeting MIA holds therapeutic potential in inhibiting tumor cell dissemination and cartilage degeneration

Productos relacionados

abx014575

Melanoma-Derived Growth Regulatory Protein (MIA) Antibody

Rabbit polyclonal antibody against MIA protein. Immunogen region is C-terminal.…

Ver producto
abx130313

Melanoma-Derived Growth Regulatory Protein (MIA) Antibody

Melanoma Inhibitory Activity Protein 1 Antibody is a Rabbit Polyclonal against Melanoma Inhibitory Activity Protein 1.…

Ver producto
abx130858

Melanoma-Derived Growth Regulatory Protein (MIA) Antibody

Melanoma-Derived Growth Regulatory Protein (MIA) Antibody is a Rabbit Polyclonal against Melanoma-Derived Growth Regulat…

Ver producto